Neurofibromatosis
FY23 Clinical Trial Award - Optional Qualified Collaboration
The list of Fiscal Year 2023 Neurofibromatosis Research Program Clinical Trial Award - Optional Qualified Collaboration applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
University of Alabama at Birmingham | Vanessa Eulo |
Last updated Monday, April 22, 2024